Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat fatty liver disease.
{iframe}https://www.fijitimes.com/roche-buys-u-s-biotech-jecure-in-race-for-liver-disease-drugs/{/iframe}